AYTU BIOPHARMA, INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for AYTU BIOPHARMA, INC (AYTU), sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are AYTU insiders buying or selling?
AYTU BIOPHARMA, INC insiders reported no open-market purchases or sales in the last 12 months. Since March 2018, Trabud has recorded 19 Form 4 filings for AYTU: 15 buys ($8.7M) and 4 sells ($40.6M).
Source: SEC EDGAR Form 4
Key Statistics (March 2018 – Jun 10, 2025)
Insider sentiment
Net sellingNet insider flow of $32.0M in net selling since March 2018.
Recent AYTU insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | Jarrett Disbrow | Chief Business Officer | Purchase | 16.7K | $1.50 | $25.0K | SEC ↗ |
| Jun 10, 2025 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 66.7K | $1.50 | $100.0K | SEC ↗ |
| Mar 3, 2025 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 15.0K | $1.30 | $19.5K | SEC ↗ |
| Jun 20, 2023 | Greg Pyszczymuka | Chief Commerical Officer | Purchase | 12.0K | $1.87 | $22.4K | SEC ↗ |
| Jun 15, 2023 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 14.0K | $1.86 | $26.1K | SEC ↗ |
| Dec 21, 2022 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 112.4K | $0.22 | $25.0K | SEC ↗ |
| Dec 21, 2022 | Greg Pyszczymuka | Chief Commercial Officer | Purchase | 100.0K | $0.24 | $24.5K | SEC ↗ |
| Nov 28, 2022 | Mark K Oki | Chief Financial Officer | Purchase | 90.0K | $0.23 | $20.7K | SEC ↗ |
| Nov 28, 2022 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 222.0K | $0.24 | $52.6K | SEC ↗ |
| Dec 16, 2020 | Steven Boyd | Director | Purchase | 1.3M | $6.00 | $8.0M | SEC ↗ |
| Apr 30, 2020 | Steven Boyd | Director | Sale | 5.1M | $1.82 | $9.3M | SEC ↗ |
| Apr 27, 2020 | Cerecor Inc. | 10% Owner | Sale | 92.8K | $1.55 | $144.1K | SEC ↗ |
| Mar 12, 2020 | Steven Boyd | Director | Sale | 22.0M | $1.42 | $31.2M | SEC ↗ |
| Dec 23, 2019 | Steven Boyd | Director, 10% Owner | Purchase | 78.8K | $0.86 | $67.7K | SEC ↗ |
| Dec 19, 2019 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 55.0K | $0.89 | $48.8K | SEC ↗ |
| Dec 26, 2018 | David A Green | Chief Financial Officer | Sale | 3.3K | $0.81 | $2.7K | SEC ↗ |
| Mar 7, 2018 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 226.1K | $0.45 | $101.7K | SEC ↗ |
| Mar 7, 2018 | David A Green | Chief Financial Officer | Purchase | 66.6K | $0.45 | $30.0K | SEC ↗ |
| Mar 7, 2018 | Jarrett Disbrow | Chief Operating Officer | Purchase | 226.1K | $0.45 | $101.7K | SEC ↗ |
Showing the 19 most recent of 19 Form 4 filings for AYTU BIOPHARMA, INC.
Most active AYTU insiders
- Joshua R. Disbrow7 filings
- Steven Boyd4 filings
- David A Green2 filings
- Greg Pyszczymuka2 filings
- Jarrett Disbrow2 filings
Ask anything about AYTU insider activity
Use Trabud's AI agent to query AYTU BIOPHARMA, INC's Form 4 history in plain English — "Show me AYTU CEO purchases this year" or compare it against any other ticker.
Open the AI agentAYTU insider trading FAQ
Are AYTU BIOPHARMA, INC insiders buying or selling?
AYTU BIOPHARMA, INC insiders reported no open-market purchases or sales in the last 12 months. Since March 2018, Trabud has recorded 19 Form 4 filings for AYTU: 15 buys ($8.7M) and 4 sells ($40.6M). Over the full record that is net selling of $32.0M.
How many insiders trade AYTU stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AYTU BIOPHARMA, INC. The most recent filing was accepted on Jun 10, 2025.
Where does Trabud get AYTU insider trading data?
All AYTU insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.